Structural Neuroplasticity Associated With Aerobic Treadmill Training in Geriatric Chronic Stroke Survivors

May 27, 2015 updated by: Andreas R Luft

Aerobic treadmill exercise has been shown to improve walking, cardiovascular fitness and thereby risk factor profiles in chronic stroke patients (Macko et al., Stroke 2005). The proposed project is a randomized controlled trial in geriatric stroke patients with chronic disabilities to investigate potential mechanisms of treadmill therapy. The hypothesis is tested that 3-months of aerobic treadmill exercise induces structural brain plasticity and reorganization. The outcome measures are walking ability, gait pattern, cardiovascular fitness and brain morphology. This study will elucidate fundamental mechanisms of brain adaptations linked to task-repetitive aerobic lower extremity exercise. These mechanisms will not only lead to a better understanding but may also help to identify predictors of treatment response.

40 patients aged over 60 years with lower extremity paresis after a first-ever clinical stroke longer than 6 months prior to study inclusion will be recruited from: 1) The Geriatric Rehabilitation Clinic at the Robert-Bosch Hospital in Stuttgart 2) the Dept of Neurology, University Hospital in Tübingen. Subjects will be randomized to 3 months progressive graded aerobic treadmill exercise training (TAEX; 3 times/week, duration 10-45 min) or an attention control group (CON). Because we expect that localization and size of stroke affect therapy outcomes, stratified randomization will be used to balance entry into groups.

We hypothesize that 3 months of treadmill gait training but not conventional care leads to improvements of cardiovascular fitness and gait and to brain reorganization (structural plasticity) in regions in which functional adaptations have been demonstrated using fMRI in previous studies. The specific aims are:

  • To assess reorganization by comparing cortical thickness, cortical density and fiber tract morphology before (time point 0), and after therapy (3 months) using T1-weighted 3D-MPRAGE images, voxel based morphometry and diffusion tensor imaging.
  • To correlate brain reorganization with improvements in walking velocity, and analysis of gait patterns (parameters, swing time, stance time, gait symmetry).
  • To correlate brain reorganization with location and size of the index stroke lesion and of diffuse white matter damage (subcortical vascular encephalopathy). Lesion and white matter damage will be evaluated based on T2-weighted FLAIR sequences.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

38

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • women and men aged > 60 years
  • first ever ischemic stroke at least prior 6 months
  • all conventional inpatient and outpatient physical therapy completed
  • residual hemiparetic gait disturbance adequate language and neurocognitive function to participate in exercise training and testing

Exclusion Criteria:

  • already performing > 20 minutes aerobic exercise 3 X/ week
  • Alcohol consumption >2 oz liquor, or 2x 4oz glasses of wine, or 2x 12 oz cans of beer per day.
  • Cardiac history of

    1. unstable angina
    2. recent (< 3 months) myocardial infarction
    3. congestive heart failure (NYHA category II)
    4. hemodynamically significant valvular dysfunction.
  • Medical History:

    1. recent hospitalization (<3 months) for severe medical disease
    2. symptomatic peripheral arterial occlusive disease
    3. orthopedic or chronic pain conditions restricting exercise
    4. pulmonary or renal failure
    5. active cancer
    6. poorly controlled hypertension (>160/100) or diabetes mellitis (fasting glucose>180 mg/dl, HbA1C >10%)
  • Neurological history of

    1. dementia
    2. receptive or global aphasia that confounds testing and training, operationally defined as unable to follow 2 point commands
    3. cognitive deficits (other than dementia and aphasia, as above)

    (e) non-stroke neuromuscular disorder restricting exercise (eg Parkinson's Syndrome) (f) untreated major depression

  • exclusion criteria for MRI scanning (metal implants (e.g. pacemaker), claustrophobia, etc.)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: A
Treadmill training group (TAEX)
3 months (3 times/week) progressive graded aerobic treadmill training with a duration of 10-45 min per training session
Active Comparator: B
Attention control group (CON)
3 months (3 times/week) progressive graded aerobic treadmill training with a duration of 10-45 min per training session

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
aerobic capacity (peak VO2)
Time Frame: Baseline (timepoint 0) and after training (3 months)
Baseline (timepoint 0) and after training (3 months)
gait velocity
Time Frame: Baseline (timepoint 0) and after training (3 months)
Baseline (timepoint 0) and after training (3 months)

Secondary Outcome Measures

Outcome Measure
Time Frame
cortical thickness (MRI)
Time Frame: Baseline (timepoint 0) and after training (3 months)
Baseline (timepoint 0) and after training (3 months)
grey matter density (VBM-MRI)
Time Frame: Baseline (timepoint 0) and after training (3 months)
Baseline (timepoint 0) and after training (3 months)
cerebrovascular reserve capacity (ASL-MRI)
Time Frame: Baseline (timepoint 0) and after training (3 months)
Baseline (timepoint 0) and after training (3 months)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2008

Primary Completion (Actual)

January 1, 2010

Study Completion (Actual)

April 1, 2010

Study Registration Dates

First Submitted

January 31, 2008

First Submitted That Met QC Criteria

January 31, 2008

First Posted (Estimate)

February 13, 2008

Study Record Updates

Last Update Posted (Estimate)

May 28, 2015

Last Update Submitted That Met QC Criteria

May 27, 2015

Last Verified

January 1, 2008

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on treadmill exercise training

3
Subscribe